forphenicinol has been researched along with Carcinoma, Epidermoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckett, MA; Jaskowiak, NT; Kimchi, E; Kufe, DW; Lopez, CA; Mauceri, HJ; Mehta, N; Murphy, KT; Ohno, T; Posner, MC; Salloum, RM; Wardak, A; Weichselbaum, RR | 1 |
1 other study(ies) available for forphenicinol and Carcinoma, Epidermoid
Article | Year |
---|---|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Drug Synergism; Female; Glycine; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiotherapy; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2005 |